| ID | 65097 |
| FullText URL | |
| Author |
Otani, Yoshihiro
Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Satomi, Kaishi
Department of Pathology, Kyorin University School of Medicine
Suruga, Yasuki
Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Ishida, Joji
Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Fujii, Kentaro
Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Ichimura, Koichi
Department of Brain Disease Translational Research, Graduate School of Medicine, Juntendo University
Date, Isao
Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
|
| Abstract | Despite the current progress of treatment, pediatric-type diffuse glioma is one of the most lethal primary malignant tumors in the central nervous system (CNS). Since pediatric-type CNS tumors are rare disease entities and highly heterogeneous, the diagnosis is challenging. An accurate diagnosis is essential for the choice of optimal treatment, which leads to precision oncology and improvement of the patient’s outcome. Genome-wide DNA methylation profiling recently emerged as one of the most important tools for the diagnosis of CNS tumors, and the utility of this novel assay has been reported in both pediatric and adult patients. In the current World Health Organization classification published in 2021, several new entities are recognized in pediatric-type diffuse gliomas, some of which require methylation profiling. In this review, we investigated the utility of genome-wide DNA methylation profiling in pediatric-type diffuse glioma, as well as issues in clinical application of this assay. Furthermore, the combination of genome-wide DNA methylation profiling and other comprehensive genomic assays, which may improve diagnostic accuracy and detection of the actionable target, will be discussed.
|
| Keywords | Genome-wide DNA methylation profiling
pediatric-type diffuse glioma
pediatric brain tumor
|
| Note | This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s10014-023-00457-6
This fulltext file will be available in Apr. 2024.
|
| Published Date | 2023-04-01
|
| Publication Title |
Brain Tumor Pathology
|
| Volume | volume40
|
| Issue | issue2
|
| Publisher | Springer Science and Business Media LLC
|
| Start Page | 56
|
| End Page | 65
|
| ISSN | 1433-7398
|
| NCID | AA11203151
|
| Content Type |
Journal Article
|
| language |
English
|
| OAI-PMH Set |
岡山大学
|
| Copyright Holders | © The Author(s), under exclusive licence to The Japan Society of Brain Tumor Pathology 2023
|
| File Version | author
|
| PubMed ID | |
| DOI | |
| Web of Science KeyUT | |
| Related Url | isVersionOf https://doi.org/10.1007/s10014-023-00457-6
|
| Citation | Otani, Y., Satomi, K., Suruga, Y. et al. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas. Brain Tumor Pathol 40, 56–65 (2023). https://doi.org/10.1007/s10014-023-00457-6
|
| Funder Name |
Ministry of Education, Culture, Sports, Science and Technology
|
| 助成番号 | 21K20803
22K16687
|